Second-Line Hormonal Therapy for Men With Chemotherapy-Naïve Castration-Resistant Prostate Cancer: American Society of Clinical Oncology Provisional Clinical Opinion Summary

J Oncol Pract. 2017 Jul;13(7):459-461. doi: 10.1200/JOP.2017.022970. Epub 2017 Apr 26.

Authors

Katherine S Virgo¹, R Bryan Rumble¹, Eric A Singer¹

Affiliation

¹ Emory University, Atlanta, GA; American Society of Clinical Oncology, Alexandria, VA; and Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.

PMID: 28445101
DOI: 10.1200/JOP.2017.022970

No abstract available

Publication types

Practice Guideline

MeSH terms

Antineoplastic Agents, Hormonal / therapeutic use*
Consensus
Humans
Male
Medical Oncology / standards
Prostatic Neoplasms, Castration-Resistant / drug therapy*
Societies, Medical
United States

Substances

Antineoplastic Agents, Hormonal